Price range: $60.00 through $212.00 / 10 Vials
Tesamorelin is a stabilized synthetic peptide analog of Growth Hormone Releasing Hormone (GHRH). It is specifically recognized in clinical research for its unique ability to target and reduce visceral adipose tissue (VAT)—the stubborn deep-belly fat—while simultaneously increasing lean muscle mass. By stimulating the pituitary gland, it promotes a natural, pulsatile release of endogenous growth hormone.
Amino Acid Sequence
(trans-3-Hexenoyl)-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2
Molecular Formula
$C_{221}H_{366}N_{72}O_{67}S$
Molecular Weight
5135.9 g/mol
PubChem CID
16137828
CAS Number
218949-48-5
Vial Size
3ml (or standard 2ml/5ml/10ml vials based on supplier)
Contents
Lyophilized powder, white/off-white color
| Size | 10mg, 5mg, 2mg |
|---|---|
| Mechanism of Action | Targeted Lipolysis: Unlike other GHRH analogs, Tesamorelin has shown a specialized affinity for mobilizing visceral fat, making it the premier choice for metabolic research. GHRH Receptor Agonist: It binds to GHRH receptors in the pituitary gland with high potency, triggering the synthesis and release of growth hormone (GH). Improved Metabolic Profile: Research suggests it helps improve insulin sensitivity and lipid profiles by elevating circulating IGF-1 levels. Structural Stability: The addition of the hexenoyl group makes it more resistant to dipeptidyl peptidase-4 (DPP-4) degradation compared to natural GHRH, ensuring longer biological activity. |
| Storage & handling | Storage:Store the lyophilized vial in a cool, dry area protected from direct sunlight. |
Only logged in customers who have purchased this product may leave a review.
All products on this site are for laboratory research, development, or analytical use only; they are NOT FOR HUMAN CONSUMPTION, medical, diagnostic, cosmetic, or veterinary applications.
These statements and products have not been evaluated by the FDA and are not intended to diagnose, treat, or prevent any disease. Genixpep is not a compounding or outsourcing facility under sections 503A/503B of the FD&C Act.
Reviews
There are no reviews yet.